Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study.
Erin S MackinnonLawrence Alan LeiterRajvi Jayant WaniNatasha BurkeEileen ShawKelcie WitgesShaun G GoodmanPublished in: Cardiology and therapy (2024)
This real-world study confirms that statin-treated high-risk patients with ASCVD and above-threshold LDL-C levels have substantial incidence of recurrent CV events. These findings reinforce the opportunity for lipid-lowering therapy intensification in high-risk patients to levels below guideline-recommended threshold in order to reduce CV risk.
Keyphrases
- cardiovascular events
- cardiovascular disease
- coronary artery disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- risk factors
- prognostic factors
- low density lipoprotein
- metabolic syndrome
- stem cells
- fatty acid
- cardiovascular risk factors
- patient reported outcomes
- cell therapy